BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2988413)

  • 1. Experimental lead neuropathy: inorganic lead inhibits proliferation but not differentiation of Schwann cells.
    Sobue G; Pleasure D
    Ann Neurol; 1985 May; 17(5):462-8. PubMed ID: 2988413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Schwann cell nerve growth factor receptor by cyclic adenosine 3',5'-monophosphate.
    Mokuno K; Sobue G; Reddy UR; Wurzer J; Kreider B; Hotta H; Baron P; Ross AH; Pleasure D
    J Neurosci Res; 1988; 21(2-4):465-72. PubMed ID: 2851058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schwann cell responses to cyclic AMP: proliferation, change in shape, and appearance of surface galactocerebroside.
    Sobue G; Shuman S; Pleasure D
    Brain Res; 1986 Jan; 362(1):23-32. PubMed ID: 3002553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retardation of Schwann cell division and axonal regrowth following nerve crush in experimental lead neuropathy.
    Ohnishi A; Dyck PJ
    Ann Neurol; 1981 Nov; 10(5):469-77. PubMed ID: 7305299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schwann cell galactocerebroside induced by derivatives of adenosine 3',5'-monophosphate.
    Sobue G; Pleasure D
    Science; 1984 Apr; 224(4644):72-4. PubMed ID: 6322307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue culture studies of neurofibromatosis: effects of axolemmal fragments and cyclic adenosine 3',5'-monophosphate analogues on proliferation of Schwann-like and fibroblast-like neurofibroma cells.
    Sobue G; Sonnenfeld K; Rubenstein AE; Pleasure D
    Ann Neurol; 1985 Jul; 18(1):68-73. PubMed ID: 2994552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue culture studies of Schwann cell proliferation and differentiation.
    Pleasure D; Kreider B; Shuman S; Sobue G
    Dev Neurosci; 1985; 7(5-6):364-73. PubMed ID: 2424706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoinositol inhibits proliferation of cultured Schwann cells: evidence for neurotoxicity of myoinositol.
    Niwa T; Sobue G; Maeda K; Mitsuma T
    Nephrol Dial Transplant; 1989; 4(7):662-6. PubMed ID: 2510066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schwann cell galactocerebroside of unmyelinated fibers is inducible by derivatives of adenosine 3',5'-monophosphate.
    Sobue G; Yasuda T; Mitsuma T; Pleasure D
    Neurosci Lett; 1986 Dec; 72(3):253-7. PubMed ID: 3029634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor prevents cAMP-induced apoptosis in cultured Schwann cells.
    Shaw R; Cianchetti R; Pleasure D; Kreider B
    J Neurosci Res; 1997 Feb; 47(4):400-4. PubMed ID: 9057133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gangliosides modulate Schwann cell proliferation and morphology.
    Sobue G; Taki T; Yasuda T; Mitsuma T
    Brain Res; 1988 Dec; 474(2):287-95. PubMed ID: 2850090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-I (IGF-I) and IGF binding protein-5 in Schwann cell differentiation.
    Cheng HL; Feldman EL
    J Cell Physiol; 1997 May; 171(2):161-7. PubMed ID: 9130463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of parathyroid hormone-related peptide following peripheral nerve injury: role as a modulator of Schwann cell phenotype.
    Macica CM; Liang G; Lankford KL; Broadus AE
    Glia; 2006 Apr; 53(6):637-48. PubMed ID: 16470617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cyclic AMP in in vitro regenerating frog sciatic nerves inhibits Schwann cell proliferation but has no effect on axonal outgrowth.
    Ekström PA
    J Neurosci Res; 1995 Sep; 42(1):54-62. PubMed ID: 8531226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased P0 glycoprotein gene expression in primary and transfected rat Schwann cells after treatment with axolemma-enriched fraction.
    Knight RM; Fossom LH; Neuberger TJ; Attema BL; Tennekoon G; Bharucha V; DeVries GH
    J Neurosci Res; 1993 May; 35(1):38-45. PubMed ID: 7685396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schwann cell responses to forskolin and cyclic AMP analogues: comparative study of mouse and rat Schwann cells.
    Yamada H; Komiyama A; Suzuki K
    Brain Res; 1995 May; 681(1-2):97-104. PubMed ID: 7552298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory products of central nervous system glial cells induce Schwann cell proliferation and protect from cytokine-mediated death.
    Lisak RP; Bealmear B; Nedelkoska L; Benjamins JA
    J Neurosci Res; 2006 Jun; 83(8):1425-31. PubMed ID: 16583376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory cytokines inhibit upregulation of glycolipid expression by Schwann cells in vitro.
    Lisak RP; Bealmear B; Benjamins J; Skoff A
    Neurology; 1998 Dec; 51(6):1661-5. PubMed ID: 9855519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axolemma is a mitogen for human Schwann cells.
    Sobue G; Brown MJ; Kim SU; Pleasure D
    Ann Neurol; 1984 May; 15(5):449-52. PubMed ID: 6329072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogenic response of rat Schwann cells to fibroblast growth factors is potentiated by increased intracellular cyclic AMP levels.
    Chen JK; Yao LL; Jenq CB
    J Neurosci Res; 1991 Oct; 30(2):321-7. PubMed ID: 1665866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.